Literature DB >> 29420

The action of cathepsin B and collagenolytic cathepsin in the degradation of collagen.

D J Etherington, P J Evans.   

Abstract

Cathepsin B and collagenolytic cathepsin were obtained from bovine spleen and human placenta and identified as thiol proteinases. Both enzymes degraded insoluble fibrous collagen maximally at pH 3.5 and soluble monomeric collagen near pH 4.5. The response to activators and inhibitors was similar for both enzymes. Collagenolytic cathepsin was unable to degrade the synthetic substrates of cathepsin B and was also shown to differ in its physico-chemical properties. Minor differences were noted in the action of these cathepsins on insoluble fibrous collagen from different tissues. It was concluded that the rate and extent of the dissolution of fibrous collagen was determined by the number and location of the interchain cross-links, the amount of the associated non-collagenous components and the type of solvent ions, but not by the collagen phenotype.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 29420

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  4 in total

Review 1.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

Review 2.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

3.  A serum antibody in patients with rheumatoid arthritis stimulates cathepsin B activity in peritoneal mouse macrophages.

Authors:  M Ostensen; B Mørland; G Husby; O P Rekvig
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Biochemical quantitation and histochemical localization of cathepsin B, dipeptidyl peptidases I and II, and acid phosphatase in pulmonary granulomatosis and fibrosis in rats.

Authors:  S H Randell; P L Sannes
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.